N/A
N=108
Transcranial Magnetic Stimulation Effects on Pain Perception
Gastric Bypass Surgery Pain Management
Bottom Line
View on ClinicalTrials.gov: NCT01861574 ↗Enrolled (actual)
108
Serious AEs
0.0%
Results posted
Aug 2018
Primary outcome: Primary: Patient Controlled Analgesia (PCA) Hydromorphone Usage — 11.77; 13.42; 12.66; 9.83 mg/ml
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Real TMS 45 min (Device); Sham TMS 45 min (Device); Real TMS 4 Hours (Device); Sham TMS 4 Hours (Device)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Medical University of South Carolina
- Primary completion
- Jun 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Controlled Analgesia (PCA) Hydromorphone Usage |
11.77; 13.42; 12.66; 9.83 | — |
| PRIMARY Sensory Dimension of McGill Pain Questionnaire |
6.33; 5.36; 4.8; 5.71; 4.5; 5.4 | — |
| PRIMARY Affective Dimension of McGill Pain Questionnaire |
2.33; 0.95; 1.29; 1.6; 1.35; 1.35 | — |
| SECONDARY Correctly Guessed Assignment Condition at 4 Hours |
53 | — |
| SECONDARY Confidence Ratings of Guessing TMS Condition Assignment |
5.40; 6.52 | — |
Summary
The purpose of this research study is to investigate the effects of Transcranial Magnetic Stimulation on pain perception. TMS is a non - invasive technique that uses electromagnetic pulses to temporarily stimulate specific brain areas in awake people (without the need for surgery, anesthetic, or other invasive procedures)
Eligibility Criteria
Inclusion Criteria
- Adult gastric by-pass patients 18 to 60 years old
Exclusion Criteria
- Non gastric by -pass patients.
Data sourced from ClinicalTrials.gov (NCT01861574). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.